233 related articles for article (PubMed ID: 12423450)
1. Review article: albumin for circulatory support in patients with cirrhosis.
Ginès P; Guevara M; De Las Heras D; Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():24-31. PubMed ID: 12423450
[TBL] [Abstract][Full Text] [Related]
2. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
3. Clinical indications for the albumin use: still a controversial issue.
Caraceni P; Domenicali M; Tovoli A; Napoli L; Ricci CS; Tufoni M; Bernardi M
Eur J Intern Med; 2013 Dec; 24(8):721-8. PubMed ID: 23790570
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of cirrhotic complications with human serum albumin].
Henriksen JH; Ring-Larsen H
Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
[No Abstract] [Full Text] [Related]
5. Review article: albumin in the treatment of liver diseases--new features of a classical treatment.
Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():1-5. PubMed ID: 12423447
[TBL] [Abstract][Full Text] [Related]
6. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
8. [The use of albumin infusion in decompensated liver cirrhosis].
Schmidt LE; Ring-Larsen H
Ugeskr Laeger; 2002 Feb; 164(9):1196-202. PubMed ID: 11899505
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
10. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
[TBL] [Abstract][Full Text] [Related]
11. Albumin: Indications in chronic liver disease.
Tufoni M; Zaccherini G; Caraceni P; Bernardi M
United European Gastroenterol J; 2020 Jun; 8(5):528-535. PubMed ID: 32213034
[TBL] [Abstract][Full Text] [Related]
12. Albumin for end-stage liver disease.
Lee JS
Korean J Intern Med; 2012 Mar; 27(1):13-9. PubMed ID: 22403494
[TBL] [Abstract][Full Text] [Related]
13. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
[TBL] [Abstract][Full Text] [Related]
14. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
[TBL] [Abstract][Full Text] [Related]
15. The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Longo N; Panella C; Ierardi E
Curr Drug Saf; 2011 Sep; 6(4):267-74. PubMed ID: 22129322
[TBL] [Abstract][Full Text] [Related]
16. Is there still a need for albumin infusions to treat patients with liver disease?
Ginès P; Arroyo V
Gut; 2000 May; 46(5):588-90. PubMed ID: 10764695
[No Abstract] [Full Text] [Related]
17. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
[TBL] [Abstract][Full Text] [Related]
18. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
19. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
